Table 1_A novel α-conotoxin [D1G, ΔQ14] LvIC decreased mouse locomotor activity.xls by Wen Wang (6570)

“…</p>Conclusion<p>Our findings indicate that α-conotoxin [D1G, ΔQ14] LvIC significantly decreased locomotor activity in mice. Additionally, it altered gene expression primarily in areas related to neuronal development, synapse formation, and neuron activity, while also reducing synapse strength. …”

Table 2_A novel α-conotoxin [D1G, ΔQ14] LvIC decreased mouse locomotor activity.xls by Wen Wang (6570)

“…</p>Conclusion<p>Our findings indicate that α-conotoxin [D1G, ΔQ14] LvIC significantly decreased locomotor activity in mice. Additionally, it altered gene expression primarily in areas related to neuronal development, synapse formation, and neuron activity, while also reducing synapse strength. …”

Exposure to biologics during pregnancy does not affect placental antibody transfer of anti-SARS-CoV-2 neutralizing antibodies, but concomitant corticosteroid exposure may decrease... by Donna E. Leet (22772478)

Consecutive time points of data collection. by Martin Matzka (2636344)

“…Effect sizes expectedly decreased over time. Physical quality of life remained relatively constant over time and was the only outcome for which social integration on admission was not a significant prognostic factor.…”

RTA408 significantly reduces RGCs loss. by Hongmei Qian (538647)

Subjects:

Average ratio of the concentrations obtained with qPCR, before and after DNase treatment, and with DAO before DNase treatment of the ISP phage stocks. by Saar Van Overfelt (20378458)

Subjects:

Average concentration of the ISP phage stocks obtained with qPCR, before and after DNase treatment, and with the DAO method before the DNase treatment. by Saar Van Overfelt (20378458)

Subjects:

Visualization of DNA in an untreated ISP phage stock by immunogold labelling. by Saar Van Overfelt (20378458)

Subjects:

Experimental set up to determine the impact of DNase treatment of ISP phage stocks with different storage periods (ISP-1, ISP-2 and ISP-3) on the quantification with qPCR and the a... by Saar Van Overfelt (20378458)

Subjects:

The catalase enzyme response of <i>A</i>. <i>albopictus</i> larvae decreased (1.5-fold) in response to <i>M</i>. <i>robertsii</i>-derived copper nanoparticles. by Perumal Vivekanandhan (4863484)

Subjects:

The activity of representative Fe-S containing enzymes and mitochondrial membrane potential decreased in <i>ssr1-2</i> mutant, and were restored by <i>sus1</i> or <i>sus2</i>. by Xuanjun Feng (8768193)

Analysis of the significantly different metabolomic features. by Bhuripit Saraphol (20855573)

Subjects:

Changes in AL (A) and SE (B) according to the treatment time estimation curve in patients given 0.125% atropine. by Zi-Rong Chen (9227618)

Subjects:

Flow diagram of the patient selection into the final analysis. by Zi-Rong Chen (9227618)

Subjects:

Patients’ demographics and clinical parameters. by Zi-Rong Chen (9227618)

Subjects:

Associations between demographic variables, In4_SED and SE changes at 6 and 12 months after 4_SED (<i><i>n</i></i> = 80). by Zi-Rong Chen (9227618)

Subjects:

Table 2 - Early identification of the efficacy of 0.125% atropine treatment for children with Myopia: A prospective pilot study by Zi-Rong Chen (9227618)

Subjects:

Average Heart Rate across pre-interview, interview and post-interview phases for High and Low Clarity and Authority groups: Heart Rate (HR) increases from pre-interview to intervie... by David Vagni (8060432)

Subjects:

Qualitative analyses of <i>U. epigea</i> bulb phytochemicals. by Martha Cebile Jobe (21175426)

Subjects:

Nucleotide sequence alignment of aflatoxin genes <i>Nor, Omt</i>, <i>Ver</i> and <i>aflR</i> treated with <i>U. epigea</i> extract, Ag/ZnO (Biosynthesized and Conventional) nanopar... by Martha Cebile Jobe (21175426)

Subjects: